Bilateral Mastectomy: No Survival Benefit in Unilateral Breast Cancer
Conexiant
July 29, 2024
A study analyzed data from 661,270 women with unilateral breast cancer, challenging the survival benefit of bilateral mastectomy.
The 20-year breast cancer-specific mortality was similar across lumpectomy, unilateral, and bilateral mastectomy groups, at approximately 16.7%.
Bilateral mastectomy reduced the risk of contralateral breast cancer but did not improve overall survival compared to unilateral surgery.
The cumulative risk of contralateral breast cancer was higher for ductal carcinoma in situ patients compared to those with invasive cancer.
The study highlighted the need for accurate risk and benefit information for patients considering bilateral mastectomy for unilateral breast cancer.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Editor
Affiliations:
Specialties:
Areas of Expertise: